CytomX Therapeutics, Inc. (CTMX)
2.56
-0.07
(-2.66%)
USD |
NASDAQ |
Oct 02, 16:00
2.555
0.00 (0.00%)
After-Hours: 20:00
CytomX Therapeutics Price : 2.56 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 2.68 | 2.68 | 2.55 | 2.56 | 2.624M |
| Oct 01, 2026 | 2.71 | 2.775 | 2.62 | 2.63 | 2.698M |
| Sep 30, 2026 | 2.78 | 2.80 | 2.70 | 2.72 | 3.221M |
| Sep 29, 2026 | 2.70 | 2.825 | 2.65 | 2.75 | 4.457M |
| Sep 28, 2026 | 2.68 | 2.76 | 2.60 | 2.69 | 2.694M |
| Sep 25, 2026 | 2.74 | 2.78 | 2.66 | 2.70 | 3.032M |
| Sep 24, 2026 | 2.75 | 2.78 | 2.68 | 2.75 | 3.082M |
| Sep 23, 2026 | 2.90 | 2.91 | 2.67 | 2.78 | 4.955M |
| Sep 22, 2026 | 2.86 | 2.995 | 2.76 | 2.94 | 7.923M |
| Sep 21, 2026 | 2.80 | 2.83 | 2.742 | 2.76 | 2.331M |
| Sep 18, 2026 | 2.83 | 2.86 | 2.72 | 2.76 | 9.598M |
| Sep 17, 2026 | 2.83 | 2.92 | 2.78 | 2.82 | 4.215M |
| Sep 16, 2026 | 2.72 | 2.865 | 2.671 | 2.765 | 6.869M |
| Sep 15, 2026 | 3.20 | 3.205 | 2.665 | 2.69 | 7.510M |
| Sep 14, 2026 | 3.335 | 3.36 | 3.145 | 3.20 | 6.139M |
| Sep 11, 2026 | 3.38 | 3.406 | 3.23 | 3.29 | 2.250M |
| Sep 10, 2026 | 3.50 | 3.52 | 3.335 | 3.35 | 2.059M |
| Sep 09, 2026 | 3.66 | 3.66 | 3.495 | 3.54 | 2.054M |
| Sep 08, 2026 | 3.612 | 3.66 | 3.58 | 3.65 | 1.985M |
| Sep 04, 2026 | 3.64 | 3.725 | 3.53 | 3.71 | 2.298M |
| Sep 03, 2026 | 3.73 | 3.82 | 3.61 | 3.68 | 2.558M |
| Sep 02, 2026 | 3.72 | 3.885 | 3.69 | 3.72 | 6.497M |
| Sep 01, 2026 | 3.32 | 3.73 | 3.32 | 3.67 | 8.821M |
| Aug 31, 2026 | 3.20 | 3.375 | 3.17 | 3.36 | 2.381M |
| Aug 28, 2026 | 3.40 | 3.42 | 3.21 | 3.21 | 2.174M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Regeneron Pharmaceuticals, Inc. | 735.20 |
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Savara, Inc. | 4.81 |
| Vericel Corp. | 40.15 |
Price Related Metrics
| PS Ratio | 25.58 |
| Price to Book Value | 1.847 |
| Earnings Yield | -17.85% |
| Market Cap | 557.82M |